Agnieszka Hobbs

London, ENG NW11AT, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Impact of First SARS-CoV-2 Infection Variant on Serological Responses Against Omicron: Findings From the SIREN Study.

Impact of First SARS-CoV-2 Infection Variant on Serological Responses Against Omicron: Findings From the SIREN Study.

Journal: Influenza and other respiratory viruses
Published: July 18, 2025

Third exposure to COVID-19 infection or vaccination differentially impacts T cell responses.

Third exposure to COVID-19 infection or vaccination differentially impacts T cell responses.

Journal: The Journal of infection
Published: July 18, 2025

Immunogenicity of three-dose COVID-19 vaccines in people living with multiple sclerosis.

Immunogenicity of three-dose COVID-19 vaccines in people living with multiple sclerosis.

Journal: BMJ neurology open
Published: June 11, 2025

Improved Resolution of Influenza Vaccination Responses With High-Throughput Live Virus Microneutralisation.

Improved Resolution of Influenza Vaccination Responses With High-Throughput Live Virus Microneutralisation.

Journal: Influenza and other respiratory viruses
Published: December 06, 2024

Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeutics.

Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeutics.

Journal: Vaccine
Published: December 04, 2024

Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study.

Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study.

Journal: The Lancet. Infectious diseases
Published: April 11, 2024

Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign.

Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign.

Journal: Lancet (London, England)
Published: January 05, 2024

SARS-CoV-2 mucosal neutralising immunity after vaccination.

SARS-CoV-2 mucosal neutralising immunity after vaccination.

Journal: The Lancet. Infectious diseases
Published: August 25, 2023

Neutralising immunity to omicron sublineages BQ.1.1, XBB, and XBB.1.5 in healthy adults is boosted by bivalent BA.1-containing mRNA vaccination and previous Omicron infection.

Neutralising immunity to omicron sublineages BQ.1.1, XBB, and XBB.1.5 in healthy adults is boosted by bivalent BA.1-containing mRNA vaccination and previous Omicron infection.

Journal: The Lancet. Infectious diseases
Published: April 06, 2023

Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein.

Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 20, 2023

WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed.

WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed.

Journal: Lancet (London, England)
Published: September 26, 2022

Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer.

Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer.

Journal: Cancer cell
Published: March 30, 2022
Showing 1-12 of 12

Last Updated: 09/26/2026